A phase 1b randomized, placebo‐controlled clinical trial with SNF472 in haemodialysis patients
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13863
Abstract: SNF472 is a calcification inhibitor that is being studied as a novel treatment for calciphylaxis and cardiovascular calcification (CVC). A first study showed acceptable safety and tolerability in a single ascending dose administration in healthy… read more here.
Keywords: haemodialysis patients; trial; haemodialysis; phase randomized ... See more keywords